Relmada Therapeutics (RLMD) Short-term Investments (2019 - 2026)
Relmada Therapeutics (RLMD) reported Short-term Investments of $206.4 million for Q2 2026, up 971.3% from $19.27 million a year earlier but down 7.9% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Short-term Investments (2019 - 2026) Analysis & Trends
At the end of FY2025, Relmada Therapeutics posted Short-term Investments of $89.51 million, up 118.0% from FY2024.
- Short-term Investments has a five-year compound annual growth rate of -4.8% (FY2020 to FY2025).
- By year, Short-term Investments came in at $41.05 million in FY2024 (-55.5%), $92.23 million in FY2023 (-35.5%), $142.93 million in FY2022 (-14.7%) and $167.47 million in FY2021 (+46.1%).
- Five-year quarterly Short-term Investments spans a low of $12.5 million in Q3 2025 and a high of $224.19 million in Q1 2026.
- Year over year, Short-term Investments has now increased in each of the last three quarters, with growth averaging 191.9% over the last eight quarters.
- The high point for year-over-year Short-term Investments in five years was Q2 2026 (growth of 971.3%); the low point was Q3 2025 (a decline of 76.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $224.19 million (Q1 2026), $89.51 million (Q4 2025) and $12.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Relmada Therapeutics | 367.47 Mn | -191.12 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 206.40 Mn |
| Mar 31, 2026 | 224.19 Mn |
| Dec 31, 2025 | 89.51 Mn |
| Sep 30, 2025 | 12.50 Mn |
| Jun 30, 2025 | 19.27 Mn |
| Mar 31, 2025 | 25.91 Mn |
| Dec 31, 2024 | 41.05 Mn |
| Sep 30, 2024 | 52.63 Mn |
| Jun 30, 2024 | 68.35 Mn |
| Mar 31, 2024 | 82.28 Mn |
| Dec 31, 2023 | 92.23 Mn |
| Sep 30, 2023 | 99.57 Mn |
| Jun 30, 2023 | 104.06 Mn |
| Mar 31, 2023 | 103.55 Mn |
| Dec 31, 2022 | 142.93 Mn |
| Sep 30, 2022 | 141.63 Mn |
| Jun 30, 2022 | 174.69 Mn |
| Mar 31, 2022 | 175.72 Mn |
| Dec 31, 2021 | 167.47 Mn |
| Sep 30, 2021 | 76.64 Mn |
API Access
Relmada Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();